ORTHO-CEPT Drug Patent Profile

✉ Email this page to a colleague

When do Ortho-cept patents expire, and when can generic versions of Ortho-cept launch?

Ortho-cept is a drug marketed by Janssen Pharms and is included in one NDA.

The generic ingredient in ORTHO-CEPT is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Ortho-cept

A generic version of ORTHO-CEPT was approved as desogestrel; ethinyl estradiol by DURAMED PHARMS BARR on August 12^th, 1999.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for ORTHO-CEPT?
What are the global sales for ORTHO-CEPT?
What is Average Wholesale Price for ORTHO-CEPT?

Summary for ORTHO-CEPT

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	4
Patent Applications:	217
DailyMed Link:	ORTHO-CEPT at DailyMed

Drug patent expirations by year for ORTHO-CEPT

Drug Sales Revenue Trends for ORTHO-CEPT

US Patents and Regulatory Information for ORTHO-CEPT

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Janssen Pharms	ORTHO-CEPT	desogestrel; ethinyl estradiol	TABLET;ORAL-21	020301-001	Dec 14, 1992		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Janssen Pharms	ORTHO-CEPT	desogestrel; ethinyl estradiol	TABLET;ORAL-28	020301-002	Dec 14, 1992		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ORTHO-CEPT

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Janssen Pharms	ORTHO-CEPT	desogestrel; ethinyl estradiol	TABLET;ORAL-21	020301-001	Dec 14, 1992	⤷ Sign Up	⤷ Sign Up
Janssen Pharms	ORTHO-CEPT	desogestrel; ethinyl estradiol	TABLET;ORAL-28	020301-002	Dec 14, 1992	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ORTHO-CEPT

See the table below for patents covering ORTHO-CEPT around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Denmark	147405		⤷ Sign Up
Netherlands	175063		⤷ Sign Up
Mexico	9203790	UN PROCEDIMIENTO PARA LA PREPARACION DE NUEVOS 11,11-ALCOHILIDEN-ESTEROIDES.	⤷ Sign Up
France	2209577		⤷ Sign Up
Belgium	808391		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for ORTHO-CEPT

Make Better Decisions: Try a trial or see plans & pricing